FDA Voice: FDA has embarked on an exciting collaboration with the Defense Advanced Research Projects Agency (DARPA) and NIH—to develop a groundbreaking tool that could help bring new treatments to patients faster, more cheaply, and more safely. Can you talk about this new technology?
Defense Advanced Research Projects Agency (DARPA)
Our baby done growed up: Aethlon books first revenues ever on DARPA deal
Aethlon Medical (OTC:AEMD) jumped from development-stage to revenue-stage with the first milestone payment of a $6.8 million contract with the U.S. Defense Advanced Research Projects Agency.
The San Diego-based company, which has developed an anti-sepsis blood filtration system, was nearly ready to shutter its doors in September after another disappointing earning report with no sales to speak of.
Aethlon Medical releases shareholder letter on maturation to revenue-stage company
SAN DIEGO, Nov. 16, 2011 /PRNewswire/ — Aethlon Medical, Inc., (OTCBB:AEMD) disclosed today that its Chairman and CEO, James A. Joyce, has issued the following letter to shareholders.
To our Shareholders:
Aethlon Medical lands $7M DARPA contract
Aethlon Medical Inc. (OTC:AEMD) won a $6.8 million contract from the Defense Advanced Research Projects Agency to develop a device to prevent combat-injured soldiers from developing sepsis.
The project will be built on the San Diego-based company’s Adapt blood filter to create an “extracorporeal blood purification device that selectively clears multiple sepsis-enabling particles from circulation to promote recovery and prevent sepsis,” according to a press release.